Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy
- PMID: 2956869
- DOI: 10.1016/0002-9149(87)90526-1
Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy
Abstract
The acute effects of enoximone on left ventricular (LV) function, myocardial oxygen metabolism and central and systemic hemodynamics were investigated in 12 patients with idiopathic dilated cardiomyopathy. Enoximone was administered intravenously at a rate of 12.5 mg/min; the average dose was 1.42 mg/kg. LV systolic pressure decreased significantly (p less than 0.01) from 128 +/- 18 to 96 +/- 16 mm Hg (mean +/- standard deviation), LV end-diastolic pressure from 16 +/- 3 to 5 +/- 3 mm Hg, LV end-diastolic volume from 288 +/- 43 to 210 +/- 58 ml, LV end-diastolic wall stress from 33 +/- 15 to 11 +/- 5 10(3) dynes/cm2 and LV peak systolic wall stress from 243 +/- 73 to 159 +/- 42 10(3) dynes/cm2. Heart rate increased from 86 +/- 18 to 100 +/- 20 beats/min, ejection fraction from 43 +/- 7 to 52 +/- 14% (p less than 0.05). Cardiac index, stroke volume index and dP/dtmax did not change significantly. Systemic vascular resistance decreased significantly (p less than 0.01) from 1,311 +/- 444 to 1,027 +/- 356 dynes s cm-5, mean pulmonary artery pressure from 13 +/- 6 to 8 +/- 2 mm Hg, mean right atrial pressure from 4 +/- 2 to 2.6 +/- 2 mm Hg and mean arterial pressure from 95 +/- 13 to 74 +/- 13 mm Hg.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.Circulation. 1989 Jul;80(1):51-64. doi: 10.1161/01.cir.80.1.51. Circulation. 1989. PMID: 2525432
-
Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.Basic Res Cardiol. 1987;82 Suppl 2:403-9. doi: 10.1007/978-3-662-11289-2_39. Basic Res Cardiol. 1987. PMID: 2959265
-
Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.J Cardiovasc Pharmacol. 1989 Dec;14(6):803-9. doi: 10.1097/00005344-198912000-00002. J Cardiovasc Pharmacol. 1989. PMID: 2481765
-
Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.Herz. 1991 Sep;16 Spec No 1:298-303. Herz. 1991. PMID: 1820296 Review.
-
Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors.Basic Res Cardiol. 1989;84 Suppl 1:197-212. doi: 10.1007/BF02650360. Basic Res Cardiol. 1989. PMID: 2530974 Review.
Cited by
-
Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.Cardiovasc Drugs Ther. 1993 Jun;7(3):337-47. doi: 10.1007/BF00880157. Cardiovasc Drugs Ther. 1993. PMID: 8364004
-
Enoximone. A review of its pharmacological properties and therapeutic potential.Drugs. 1991 Dec;42(6):997-1017. doi: 10.2165/00003495-199142060-00008. Drugs. 1991. PMID: 1724645 Review.
-
Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.Curr Cardiol Rep. 2001 May;3(3):224-31. doi: 10.1007/s11886-001-0027-8. Curr Cardiol Rep. 2001. PMID: 11305977 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources